- CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response2006 | Faculty of Pharmacy in Hradec Králové
- Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients2017 | First Faculty of Medicine
- Pupillometry in healthy volunteers as a biomarker of tramadol efficacy2011 | First Faculty of Medicine
- Contribution of ABCB1 and CYP2D6 Genotypes to the Outcome of Tamoxifen Adjuvant Treatment in Premenopausal Women With Breast Cancer2015 | First Faculty of Medicine
- Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics2021 | First Faculty of Medicine